First commercial sale of VertX, the cutting-edge, label-free live microscope module at William Morey General Hospital, enabling high‑resolution imaging of biopsies to support infection research and personalized treatment
Discover how Edinburgh Analytical’s UV-Vis and fluorescence solutions are addressing the growing challenge of olive oil authenticity testing
New AI-powered FAIR-MS initiative aims to unlock value from historical mass spectrometry data
Automation-friendly solution delivers fast, reliable total RNA extraction for high-throughput and time-sensitive workflows
Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients
The new project invites the public to submit soil samples from chemically impacted land to investigate how soil microbes evolve to break down or transform chemical contaminants
Recognizing the most impactful technologies and content across both life sciences and general lab workflow, as voted for by scientists worldwide
ClarosTechUV delivers commercial-scale performance in complex remediation conditions using PFAS concentrate from Lake Elmo Minnesota site
Lumipulse G pTau 217 Plasma test supports identification of amyloid pathology in patients with cognitive decline
As Candida auris and carbapenem-resistant Enterobacterales rise, join us online to explore how emerging approaches such as next-generation sequencing and rapid susceptibility testing may support antimicrobial stewardship — plus, ask your questions in the live Q&A
Strategic partnership is focused on reducing laboratory plastic waste while advancing sustainability, performance and transparency
MAIA integrates intelligent, context‑aware support into microwave digestion systems to streamline laboratory operations
Exploring how secondary ion mass spectrometry enables high‑resolution analysis of diffusion, ion exchange, and contamination in solids
New platform leverages the established Curator platform methodology to industrialize Lentivirus processes from concept to clinic
Despite advances in biomarker testing, real-world data shows progress is not translating into treatment decisions, with the largest patient loss now occurring at the point of treatment decision
